Genetic Engineering

CRISPR Technology Synthetic Biology mRNA Technology Gene Editing CRISPR Cloning Gene Therapy Genome Editing Insect Control Conservation Technology

7 ARTICLES

last wk.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

A successful late‑stage readout may clear the way for regulatory filings while full efficacy numbers, survival data and manufacturing plans are still pending.

21 ARTICLES

last wk.

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

3 ARTICLES

last wk.

Yeast‑Made M2 Nanoparticle Vaccine Protects Mice From Multiple Flu Strains

3 ARTICLES

3w ago

Genome-Wide CRISPR Screen Identifies Two Human Genes That Boost Nonviral Editing

7 ARTICLES

3w ago

Screwworm Detections Limited in U.S. as New Dashboard and Genetic Tools Support Response

3 ARTICLES

3w ago

University of Minnesota Team Publishes SpudCell, a Synthetic Cell That Completes a Lab Life Cycle

4 ARTICLES

2mo ago

University of Minnesota Reports Synthetic 'SpudCell' That Eats, Grows, Divides and Evolves

3 ARTICLES

2mo ago

Dolly at 30: The Cloned Sheep That Changed Biology

38 ARTICLES

2mo ago

University of Minnesota Team Publishes 'SpudCell,' A Chemically Built Cell That Feeds, Grows and Divides

11 ARTICLES

2mo ago

Researchers Report a Chemically Defined Synthetic Cell That Grows and Divides

6 ARTICLES

2mo ago

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

12 ARTICLES

2mo ago

Mexico Reopens Metapa Sterile‑Fly Plant to Fight Screwworm Resurgence

7 ARTICLES

2mo ago

Japanese Venture Announces Plans for First Clinical Trials of Gene‑Edited Pig Kidneys

11 ARTICLES

2mo ago

Fish and Wildlife Signs MOU With Colossal to Build National BioVault for ESA Species

7 ARTICLES

2mo ago

Cambridge Team Uses Base Editing to Knock Out NANOG and Expose Limits of Embryo Editing

10 ARTICLES

2mo ago

European Parliament Approves Limited Use of Genome-Edited Crops

Genetic Engineering

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

Yeast‑Made M2 Nanoparticle Vaccine Protects Mice From Multiple Flu Strains

Genome-Wide CRISPR Screen Identifies Two Human Genes That Boost Nonviral Editing

Screwworm Detections Limited in U.S. as New Dashboard and Genetic Tools Support Response

Scientists Produce Two Beagles Lacking the Main Dog Allergen

Screwworm Reappears in U.S., Tracked in South Texas and New Mexico

Bryan Johnson Says He ‘Cloned’ Himself as a Newborn

Mexico Starts Sterile‑Fly Campaign With Releases Set for Tamaulipas

University of Minnesota Team Publishes SpudCell, a Synthetic Cell That Completes a Lab Life Cycle

Never miss stories about

Genetic Engineering

University of Minnesota Reports Synthetic 'SpudCell' That Eats, Grows, Divides and Evolves

Dolly at 30: The Cloned Sheep That Changed Biology

University of Minnesota Team Publishes 'SpudCell,' A Chemically Built Cell That Feeds, Grows and Divides

Researchers Report a Chemically Defined Synthetic Cell That Grows and Divides

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

Mexico Reopens Metapa Sterile‑Fly Plant to Fight Screwworm Resurgence

Japanese Venture Announces Plans for First Clinical Trials of Gene‑Edited Pig Kidneys

Fish and Wildlife Signs MOU With Colossal to Build National BioVault for ESA Species

Cambridge Team Uses Base Editing to Knock Out NANOG and Expose Limits of Embryo Editing

European Parliament Approves Limited Use of Genome-Edited Crops

Never miss stories about

Genetic Engineering